Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,439 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,769
Recruiting: 1,009
Ph III recruiting: 99
Growth YoY: −2.8%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.6%
Trials / 1,000 deaths: 75 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,350)

clinicaltrialsPublishedShowing 3,101–3,150 of 3,502 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00003171	Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome	completed	Phase 2	—	Barbara Ann Karmanos Cancer InstituteOTHER	1	Apr 5, 2013	clinicaltrials
NCT00852163	Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen	completed	Phase 2	20	Baylor Research InstituteOTHER	1	Apr 4, 2013	clinicaltrials